Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 222Liver Neoplasms 68Neoplasms 18Pancreatic Neoplasms 16Neoplasm Metastasis 14Colorectal Neoplasms 12Rectal Neoplasms 8Stomach Neoplasms 7Colonic Neoplasms 7Carcinoma, Renal Cell 6Carcinoma 6Liver Diseases 5Gallbladder Neoplasms 5Breast Neoplasms 5Digestive System Neoplasms 4Bile Duct Neoplasms 4Prostatic Neoplasms 3Kidney Neoplasms 3Esophageal Neoplasms 3Adenocarcinoma 3Neoplasms, Glandular and Epithelial 2Neoplasms by Site 2Neoplasms by Histologic Type 2Multiple Myeloma 2Melanoma 2Hepatoblastoma 2Hepatitis C 2Hepatitis B 2Hematologic Neoplasms 2Glioblastoma 2

Interventions

Gemcitabine 3pembrolizumab 2napabucasin 2entinostat 2Taxes 2Sunitinib 2Sorafenib 2130-nm albumin-bound paclitaxel 2trametinib 1siltuximab 1repotrectinib 1pralsetinib 1lutetium Lu 177 dotatate 1linifanib 1durvalumab 1dabrafenib 1copper dotatate CU-64 1cobimetinib 1capmatinib 1atezolizumab 1Vemurafenib 1Pemetrexed 1Paclitaxel 1Lutetium-177 1Lutetium 1Leucovorin 1Irinotecan 1Immunotherapy 1HhAntag691 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms by Histologic Type × Sorafenib × Gastrointestinal × Clear all
NCT01009593 2012-09-10

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Abbott

Phase 3 Terminated
1,035 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT01556815 2012-04-25

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

Shandong Cancer Hospital and Institute

Phase 2 Unknown
40 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡